IL152461A0 - Directly compressed solid dosage articles - Google Patents

Directly compressed solid dosage articles

Info

Publication number
IL152461A0
IL152461A0 IL15246101A IL15246101A IL152461A0 IL 152461 A0 IL152461 A0 IL 152461A0 IL 15246101 A IL15246101 A IL 15246101A IL 15246101 A IL15246101 A IL 15246101A IL 152461 A0 IL152461 A0 IL 152461A0
Authority
IL
Israel
Prior art keywords
solid dosage
directly compressed
compressed solid
copolymer
active ingredient
Prior art date
Application number
IL15246101A
Other languages
English (en)
Original Assignee
Noveon Ip Holdings Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noveon Ip Holdings Corp filed Critical Noveon Ip Holdings Corp
Publication of IL152461A0 publication Critical patent/IL152461A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL15246101A 2000-04-27 2001-04-17 Directly compressed solid dosage articles IL152461A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/559,687 US6623756B1 (en) 2000-04-27 2000-04-27 Directly compressed solid dosage articles
PCT/US2001/012400 WO2001082894A2 (en) 2000-04-27 2001-04-17 Directly compressed solid dosage particles

Publications (1)

Publication Number Publication Date
IL152461A0 true IL152461A0 (en) 2003-05-29

Family

ID=24234605

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15246101A IL152461A0 (en) 2000-04-27 2001-04-17 Directly compressed solid dosage articles
IL152461A IL152461A (en) 2000-04-27 2002-10-24 Directly compressed solid dosage articles

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL152461A IL152461A (en) 2000-04-27 2002-10-24 Directly compressed solid dosage articles

Country Status (13)

Country Link
US (1) US6623756B1 (de)
EP (1) EP1276466B1 (de)
JP (1) JP2003531848A (de)
CN (1) CN1195498C (de)
AT (1) ATE255886T1 (de)
BR (1) BR0110287A (de)
CA (1) CA2407140A1 (de)
DE (1) DE60101468T2 (de)
ES (1) ES2211796T3 (de)
IL (2) IL152461A0 (de)
MX (1) MXPA02010437A (de)
WO (1) WO2001082894A2 (de)
ZA (1) ZA200208571B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985420B2 (en) * 2000-04-28 2011-07-26 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US8012504B2 (en) * 2000-04-28 2011-09-06 Reckitt Benckiser Inc. Sustained release of guaifenesin combination drugs
US7838032B2 (en) * 2000-04-28 2010-11-23 Reckitt Benckiser Inc. Sustained release of guaifenesin
US6955821B2 (en) 2000-04-28 2005-10-18 Adams Laboratories, Inc. Sustained release formulations of guaifenesin and additional drug ingredients
US6623754B2 (en) * 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20030012820A1 (en) * 2001-06-12 2003-01-16 Upadhyay Ajay Hasmukhlal Compressible guaifenesin compositions, method for making same and method for making compressed guaifenesin dosage forms therefrom
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20040185016A1 (en) * 2002-07-30 2004-09-23 Popp Karl F Compositions for treatment of hyperpigmentation and methods for making and using such compositions
US20040219210A1 (en) * 2003-05-01 2004-11-04 Jian-Hwa Guo Controlled release solid dosage nifedipine formulations
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
US7704522B2 (en) * 2004-09-08 2010-04-27 Clyde Morgan Topical medicament
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
FI20080346A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi lisäaineita sisältävän tabletin valmistamiseksi
FI20080355A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi metforminia käsittävien tablettien valmistamiseksi
FI20080353A0 (fi) * 2008-05-09 2008-05-09 Atacama Labs Oy Prosessi erittäin korkean lääkepitoisuuden tabletin valmistamiseksi
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
CN101467988B (zh) * 2007-12-27 2014-07-09 北京德众万全医药科技有限公司 一种含有氨酚伪麻的药用组合物及其制备方法
EP2379993A1 (de) * 2008-12-17 2011-10-26 AstraZeneca AB Verfahren zur ausgabe einer zieldosis, pulverausgabegerät und seine verwendung
TW201117812A (en) 2009-08-05 2011-06-01 Idenix Pharmaceuticals Inc Macrocyclic serine protease inhibitors
WO2011056764A1 (en) 2009-11-05 2011-05-12 Ambit Biosciences Corp. Isotopically enriched or fluorinated imidazo[2,1-b][1,3]benzothiazoles
RU2554087C2 (ru) 2009-12-18 2015-06-27 Айденикс Фармасьютикалз, Инк. 5,5-конденсированные ариленовые или гетероариленовые ингибиторы вируса гепатита с
WO2011094890A1 (en) 2010-02-02 2011-08-11 Argusina Inc. Phenylalanine derivatives and their use as non-peptide glp-1 receptor modulators
WO2011112689A2 (en) 2010-03-11 2011-09-15 Ambit Biosciences Corp. Saltz of an indazolylpyrrolotriazine
ES2581840T3 (es) 2010-09-01 2016-09-07 Ambit Biosciences Corporation Pirazolilaminoquinazolina ópticamente activa y composiciones farmacéuticas y métodos de uso de la misma
AU2011296046B2 (en) 2010-09-01 2015-05-14 Ambit Biosciences Corporation Hydrobromide salts of a pyrazolylaminoquinazoline
WO2012078649A1 (en) 2010-12-06 2012-06-14 Follica, Inc. Methods for treating baldness and promoting hair growth
WO2012080050A1 (en) 2010-12-14 2012-06-21 F. Hoffmann-La Roche Ag Solid forms of a phenoxybenzenesulfonyl compound
CA2825152A1 (en) 2011-01-31 2012-08-09 Celgene Corporation Pharmaceutical compositions of cytidine analogs and methods of use thereof
AR085352A1 (es) 2011-02-10 2013-09-25 Idenix Pharmaceuticals Inc Inhibidores macrociclicos de serina proteasa, sus composiciones farmaceuticas y su uso para tratar infecciones por hcv
US20120252721A1 (en) 2011-03-31 2012-10-04 Idenix Pharmaceuticals, Inc. Methods for treating drug-resistant hepatitis c virus infection with a 5,5-fused arylene or heteroarylene hepatitis c virus inhibitor
EP2852586A1 (de) 2012-03-16 2015-04-01 Axikin Pharmaceuticals, Inc. 3,5-diaminopyrazol-kinaseinhibitoren
NZ631142A (en) 2013-09-18 2016-03-31 Axikin Pharmaceuticals Inc Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
EP3046924A1 (de) 2013-09-20 2016-07-27 IDENIX Pharmaceuticals, Inc. Inhibitoren des hepatitis-c-virus
WO2015134560A1 (en) 2014-03-05 2015-09-11 Idenix Pharmaceuticals, Inc. Solid forms of a flaviviridae virus inhibitor compound and salts thereof
US10202398B2 (en) 2014-03-20 2019-02-12 Capella Therapeutics, Inc. Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer
MX2016012097A (es) 2014-03-20 2017-04-27 Capella Therapeutics Inc Derivados de bencimidazol como inhibidores de tirosina cinasa erbb para el tratamiento del cáncer.
MY191736A (en) 2014-12-23 2022-07-13 Axikin Pharmaceuticals Inc 3,5-diaminopyrazole kinase inhibitors
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
CN113329810A (zh) 2019-01-24 2021-08-31 诺和诺德股份有限公司 辊压机和使用辊压机的干法制粒方法
EP4025353A1 (de) 2019-09-06 2022-07-13 Novo Nordisk A/S Verfahren und vorrichtung zur fraktionierung von granulaten zur verwendung in pharmazeutischen zusammensetzungen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2798053A (en) * 1952-09-03 1957-07-02 Goodrich Co B F Carboxylic polymers
US3915921A (en) * 1974-07-02 1975-10-28 Goodrich Co B F Unsaturated carboxylic acid-long chain alkyl ester copolymers and tri-polymers water thickening agents and emulsifiers
US4267103A (en) * 1978-12-07 1981-05-12 The B. F. Goodrich Company Solvent polymerization of carboxyl containing monomers
DE3888520T2 (de) * 1988-03-30 1994-07-21 Japan Synthetic Rubber Co Ltd Hoch vernetzte Polymerteilchen und Verfahren zur Herstellung derselben.
EP0643737B1 (de) * 1992-05-09 2001-11-21 Surfachem Group Limited Umwandlung von pulverförmigen polymeren
US5288814A (en) * 1992-08-26 1994-02-22 The B. F. Goodrich Company Easy to disperse polycarboxylic acid thickeners
US5780055A (en) * 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension

Also Published As

Publication number Publication date
DE60101468D1 (de) 2004-01-22
EP1276466A2 (de) 2003-01-22
ATE255886T1 (de) 2003-12-15
CN1195498C (zh) 2005-04-06
BR0110287A (pt) 2003-02-18
ES2211796T3 (es) 2004-07-16
CN1426297A (zh) 2003-06-25
US6623756B1 (en) 2003-09-23
DE60101468T2 (de) 2004-10-28
JP2003531848A (ja) 2003-10-28
WO2001082894A2 (en) 2001-11-08
EP1276466B1 (de) 2003-12-10
ZA200208571B (en) 2003-08-19
IL152461A (en) 2007-08-19
WO2001082894A3 (en) 2002-02-21
MXPA02010437A (es) 2003-04-25
CA2407140A1 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
IL152461A0 (en) Directly compressed solid dosage articles
MX358033B (es) Forma de dosificación farmacéutica sólida que comprende al menos un inhibidor de proteasa de hiv.
CA2385890A1 (en) Controlled release compositions comprising nimesulide
MX9701465A (es) Formulacion de acetaminofeno, de liberacion sostenida.
CA2463583A1 (en) Highly compressible ethylcellulose for tableting
AU2001236207A1 (en) Powder formulation
CA2217462A1 (en) Controlled release biodegradable micro- and nanospheres containing cyclosporin
EP2165703A3 (de) Direktkomprimierte Formulierung und Verfahren
CA2231195A1 (en) Sustained release matrix for high-dose insoluble drugs
NZ325844A (en) A bioadhesive tablet comprising a c16-c22alkyl fumarate as lubricant
CA2152795A1 (en) Readily available konjac glucomannan sustained release excipient
WO2006035417A3 (en) Dihydropyrimidine microcapsule - formulations
HK1046620A1 (en) Process for manufacturing a pharmaceutical chewinggum
BG102228A (en) Medicamentous form with controlled release of slightly soluble medicamentous substances
UA84266C2 (uk) Дозована лікарська форма у вигляді таблетки або пелети для перорального введення, яка містить інгібітор pde 4 та полівінілпіролідон, способи її одержання та застосування
CA2009135A1 (en) Modified release gemfibrozil composition
WO2002089773A3 (en) Pharmaceutical compositions comprising cyclosporin
AU2793989A (en) Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained
WO2002087546A3 (en) Method for manufacturing a low dose pharmaceutical composition
PT1195160E (pt) Composições farmacêuticas de trimetazidina de libertação sustentada e método para a sua preparação
WO2005115346A3 (en) Pharmaceutical composition containing risperidone
CA2339193A1 (en) Pharmaceutical compositions comprising ibuprofen and domperidone
ES2174734A1 (es) Nueva formulacion galenica de paracetamol dispersable y soluble, procedimiento para su preparacion y aplicaciones.
CA2454449C (en) Synergistic filler composition of pvp-va and silicified mycrocrystalline cellulose for tablet dosage form
CA2473718A1 (en) Immediate-release pharmaceutical dosage form comprising polymorphous tibolone

Legal Events

Date Code Title Description
HC Change of name of proprietor(s)

Owner name: NOVEON, INC

Free format text: FORMER NAME:NOVEON IP HOLDINGS CORP.

FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)

Owner name: LUBRIZOL ADVANCED MATERIALS, INC.

Free format text: FORMER NAME:NOVEON, INC